MLTX
MoonLake Immunotherapeutics · Healthcare · Market cap $906.4M
Insiders sold $9.6M net in the last 90 days ·3 sellers, 0 buyers· 15 of 15 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 29, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$83.0M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Jul 29, 2026
Reich Kristian
MoonLake Immunotherapeutics (MLTX) has 20 SEC Form 4 filings (34 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 29, 2026.
Inside the rolling window, 4 insiders at MoonLake Immunotherapeutics reported no open-market purchases and 25 open-market sales totaling $83.0M. The most active filer is Chief Scientific Officer Reich Kristian with 10 filings. Insiders have net sold $77.0M over the trailing 6 months. The most recent open-market filing is a sale of 1,100 shares by Chief Scientific Officer Reich Kristian, dated Jul 27, 2026, worth $22K.
- Industry:Biotechnology
- CEO:Jorge Santos da Silva
- Employees:130
- HQ:Zug, ZG, CH
- IPO:2020-10-20
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 1,100 | $22K | Jul 29 | -42.1% | SEC ↗ | |
| Chief Scientific Officer | Sale | 50,000 | $1.0M | Jul 23 | -45.0% | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,448 | $49K | Jul 23 | -45.0% | SEC ↗ | |
| Chief Scientific Officer | Sale | 43,700 | $878K | Jul 21 | -46.9% | SEC ↗ | |
| Chief Scientific Officer | Sale | 16,105 | $322K | Jul 20 | -44.1% | SEC ↗ | |
| Chief Executive Officer | Sale | 33,936 | $679K | Jul 13 | -47.8% | SEC ↗ | |
| Chief Executive Officer | Sale | 68,289 | $1.4M | Jul 13 | -47.8% | SEC ↗ | |
| Chief Executive Officer | Sale | 47,775 | $957K | Jul 2 | -43.8% | SEC ↗ | |
| Chief Financial Officer | Sale | 39,120 | $862K | Jun 23 | -49.8% | SEC ↗ | |
| Chief Financial Officer | Sale | 15,082 | $297K | Jun 18 | -44.6% | SEC ↗ | |
| Chief Financial Officer | Sale | 2,794 | $55K | Jun 18 | — | SEC ↗ | |
Reich KristianFirst in 6 months | Chief Scientific Officer | Sale | 50,000 | $945K | Jun 17 | — | SEC ↗ |
Reich KristianFirst in 6 months | Chief Scientific Officer | Sale | 50,000 | $935K | Jun 17 | — | SEC ↗ |
Reich KristianFirst in 6 months | Chief Scientific Officer | Sale | 50,000 | $972K | Jun 17 | — | SEC ↗ |
| Chief Financial Officer | Sale | 13,653 | $273K | May 13 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,426 | $47K | Apr 16 | — | SEC ↗ | |
Santos da Silva JorgeFirst in 4 months | Chief Executive Officer | Sale | 98,127 | $1.8M | Apr 14 | — | SEC ↗ |
Santos da Silva JorgeFirst in 4 months | Chief Executive Officer | Sale | 51,873 | $946K | Apr 14 | — | SEC ↗ |
Bodenstedt MatthiasFirst filing | Chief Financial Officer | Sale | 85,870 | $1.6M | Apr 10 | — | SEC ↗ |
Bodenstedt MatthiasFirst filing | Chief Financial Officer | Sale | 1,925 | $38K | Apr 10 | — | SEC ↗ |
BVF PARTNERS L P/ILFirst filing | Director, 10% Owner | Sale | 3,750,000 | $63.0M | Apr 2 | — | SEC ↗ |
Reich KristianFirst filing | Chief Scientific Officer | Sale | 130,000 | $2.0M | Dec 10 | — | SEC ↗ |
Reich KristianFirst filing | Chief Scientific Officer | Sale | 72,908 | $1.1M | Dec 10 | — | SEC ↗ |
Santos da Silva JorgeFirst filing | Chief Executive Officer | Sale | 130,000 | $2.0M | Dec 10 | — | SEC ↗ |
Santos da Silva JorgeFirst filing | Chief Executive Officer | Sale | 70,000 | $1.0M | Dec 10 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does MLTX have?
MoonLake Immunotherapeutics (MLTX) has 20 SEC Form 4 filings (34 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Jul 29, 2026.
When was the most recent SEC Form 4 filing for MLTX?
The most recent Form 4 filing for MLTX on Tracefour is dated Jul 29, 2026.
Who is the most active insider at MLTX?
The most active SEC Form 4 filer at MLTX in the rolling window is Chief Scientific Officer Reich Kristian, with 10 filings.
What is the net insider flow at MLTX over the last 6 months?
Over the trailing 180 days, insiders at MLTX have net sold $77.0M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MLTX in the current window?
Inside the rolling window, insiders at MLTX bought $0 and sold $83.0M based on SEC Form 4 filings.
Can I get alerts for MLTX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MoonLake Immunotherapeutics (MLTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
MoonLake Immunotherapeutics is in the Healthcare sector.